Relapse
PTB
ADVERSE EVENT
For the final analysis, we took patients who had successfully completed their six months of treatment having been cured of PTB and further completed18 months of follow up (697 out of 846). 149 participants were censored of which 118 were lost to follow-up, 21 had adverse event and 10 patients expired.There were 14 (4%) relapses in vitamin D arm and 19 (5.5%) relapses in placebo arm (n = 697 patients, n = 149 censored), which was however not statistically significant (p = 0.29) (